Karen Merritt, Patient Advocate at Advocates for Universal DPD/DPYD Testing, shared a post on LinkedIn:
”Hot off the presses!
FDA updated Xeloda/capecitabine labeling with a boxed warning to include testing for DPYD variants BEFORE treatment!”
More posts featuring Capecitabine.